Regenxbio Gets Breath Of Fresh Air From US FDA For Navsunli In MPS II Scrip Pharma Intelligence 22:24 Mon, 22 Jun
Regenxbio Stock Gains 11% Over Alignment With FDA For Navsunli Bla Resubmission RTT News 16:08 Mon, 22 Jun
Regenxbio Rises In Premarket As FDA Says No New Studies Needed For Navsunli Bla Resubmission RTT News 14:04 Mon, 22 Jun
Regenxbio Announces Alignment with FDA on Path Forward for Navsunli™ Bla Resubmission for Accelerated Approval; First Potential Gene Therapy for Mps II PR Newswire (Press Release) 12:36 Mon, 22 Jun
